Literature DB >> 21264117

Possible role of hydrogen sulfide in insulin secretion and in development of insulin resistance.

Ma Patel1, Gb Shah.   

Abstract

H(2)S has been proposed as physiological important molecule. It is considered as first endogenous gaseous K(+) channel opener. K(+) ATP channel activity is mainly responsible for insulin secretion. K(+)ATP channel opening of β cells leads to inhibition of insulin secretion and channels closing leads to secretion. H2S is the gaseous K(+) ATP channel opener but it does not have channel specificity. So, H(2)S may have some effect on insulin secretion. H(2)S is high in Zuker diabetic fatty rats. That means H(2)S is high in insulin resistance condition. We tried to find out the role of H(2)S in insulin secretion and in development of insulin resistance. From the result of our study, H(2)S have K(+) ATP channel opening activity on β cells. H(2)S does not have any role in the development of insulin resistance. Decrease in insulin level in Zuker diabetic rat and streptozotocin-induced diabetic rat is due to high H(2)S level.

Entities:  

Keywords:  Glucose; K+ ATP channel; hydrogen sulfide; insulin

Year:  2010        PMID: 21264117      PMCID: PMC3021689          DOI: 10.4103/0975-1483.63156

Source DB:  PubMed          Journal:  J Young Pharm        ISSN: 0975-1483


INTRODUCTION

In recent years, interest has been directed toward other naturally occurring gases, notably H2S. Now, H2S has been proposed as physiological important molecule. Recently, high concentration of H2S has been observed in brain of rats, humans, and cows. The H2S concentration in rat serum has been found to be 46 μM[1] and in brain tissue 50-160 μM.[2] Significant amount of H2S is produced in various tissues. Cystathionine gamma lyase (CSE), cystathionine β synthase (CBS), and 3-mercaptosulfurtransferase are the enzymes responsible for production of H2S.[3] The main subtract for these enzymes is L-cysteine. H2S is considered as endogenous vasorelaxant factor and cardiovascular function regulator.[4] Zhao showed that H2S is the first gaseous K+ATP channel opener.[1] Intravenous injection of H2S provoked a transient but significant decrease in mean arterial blood pressure. H2S-induced decrease in blood pressure was antagonized by glibenclamide and mimicked by pinacidil.[1] Glibenclamide and pinacidil are specific KATP channel blocker and opener, respectively. Thus, these in vivo results indicated that the hypotensive effect of H2S was likely provoked by the relaxation of resistance blood vessels through the opening of KATP channels. Its mechanism of K+ATP channel opening is still unknown, but it does not affect ATP concentration. K+ATP channel activity is mainly responsible for insulin secretion. K+ATP channel opening of β cells leads to inhibition of insulin secretion and channels closing leads to secretion. H2S is the gaseous K+ ATP channel opener but it does not have channel specificity. So, H2S has some effect on insulin secretion. H2S concentration in Zuker diabetic rats was found to be high.[5] That means H2S is high in insulin resistance condition. According to Muhammed, experimental diabetes in rats induced by streptozotocin leads to increase expression of the H2S producing enzymes.[6] H2S may have an inhibitory effect of insulin secretion due to nonspecific K+ ATP channel opening activity. On the other side, H2S level is high in hyperinsulinemia. So, this study was carried out to investigate the role of H2S in insulin secretion and development of insulin resistance.

MATERIALS AND METHODS

Animals

Adult albino rats of either sex (Wistar strain) weighing between 200 and 250 g were used for the study. The animals were fed ad libitum with standard pellet diet and had free access to water. All experiments and protocols described in present report were approved by the Institutional Animal Ethics Committee (IAEC).

Experimental protocol

Effect of H2S on the K+ATP channel of insulin secreting cell was studied by dividing animals into two groups. Group 1 received NaHS 2 mg/kg i.p. (high rate of mortality on higher dose), and Group 2 received only saline. In the second experiment, animals were divided into two groups. Group 1 received saline only and group 2 received glibenclamide 10 mg/kg, p.o[7] then after NaHS 2 mg/kg i.p. Blood was collected from tail vein at 0, 30, 60, 120 min after administration of drugs up to 5 h and blood glucose and insulin were measured. The blood glucose was measured by the GOD/POD[8] method and insulin was measured by RIA.[9]

Protocol to study the role of H2S in insulin resistance development

The wistar albino rats are divided into two groups (n=6). One group received NaHS 2 mg/kg i.p twice a day for 30 days. Another group received only saline. The development of insulin resistance was studied by performing oral glucose tolerance test (OGTT). Also OGTT was performed after giving insulin by i.m. to measure sensitivity toward exogenous insulin. Insulin and glucose level were also measured before and after 30 days treatment.

Oral Glucose Tolerance Test (OGTT)

After 30 days, 5 g/kg of glucose was administered to fasted animals. Blood samples were collected from tail vein under light anesthesia for 0 min and 15, 30, 60, 90 and 120 min after oral glucose administration. The blood samples were allowed to clot and serum was separated by centrifugation. The samples were measured for glucose level by the GOD/POD method.[10]

Oral Glucose Tolerance Test (OGTT) with Insulin

Wistar rats were divided into two groups of six animals. One is treated with NaHS 2 mg/kg for 30 days other is treated with saline. After 30 days animals were orally administered with 5 g/kg of glucose and insulin 1 U/kg i.m. Blood samples were collected from tail vein under light anesthesia before 0 min and 15, 30, 60, 90 and 120 min after oral glucose administration. The samples were allowed to clot and serum was separated by centrifugation. The samples were measured for glucose level by the GOD/POD method.[10]

Measurement of serum H2S level in streptozotocin-induced diabetic rat

Type II diabetes was induced in wistar rats by streptozotocine.[11] After induction of diabetes, H2S level in serum was measured. Seventy-five microliters of plasma were mixed with 250 μl of 1% w/v zinc acetate and 425 μl distilled water. Then 20 mM N-dimethyl-p-phenylenediamine sulfate in 7.2 mM HCl (133 μl) and 30 mM FeCl3 in 1.2 mM HCl (133 μl) were also added to the test tube for 10-min incubation at room temperature. The protein in the plasma was removed by adding 250 μl of 10% tricholoacetic acid to the reaction mixture and pelleted by centrifugation at 14 000 g (5 min). The absorbance of the resulting solution at 670 nm was measured with a spectrophotometer (TECAN Systems) in a 96-well plate. All samples were assayed in duplicate, and concentration in the solution was calculated against a calibration curve of NaHS (3.125–250 μM). Results show plasma H2S concentration in micromolar[12]

Statistical analysis

All the values were expressed as mean ± SEM. The statistical analysis was performed using Student’s unpaired t-test and by AUC comparison. Value of P less than 5% (P< 0.05) was considered statistically significant.

RESULTS

Effect of H2S on insulin and glucose level

After administration of H2S (2 mg/kg), glucose insulin level were measured. Administration of H2S results in an increase in glucose level and a decrease in insulin level which became normal after 5 h [Table 1]. After administration of glibenclamide 10 mg/kg, p.o H2S was given. Insulin and glucose level in animal treated with glibenclamide and H2S was not significantly changed compared to saline-treated animals. That means effect of H2S was inhibited by glibenclamide [Table 2].
Table 1

Effect of H2S on glucose and insulin level

Time (min)Glucose (mg %)
Insullin(μU/ml)
Saline treatedH2S treatedSaline treatedH2S treated
079.9±2.780.1±6.140 ±1.941.3 ±1.73
3085.9±3.6112.3±7.1*40.7 ±1.734.7±1.5*
6089.1±5.2142.7±8.3*43.7±0.930.5 ±1.01*
12089.6±4.1174.7±7.3*43.2±2.432.7±2.9*
18088.7±4164.2±8.5*39.8 ±233.8 ±2.29*
24084.4±6.3132.8±7.9*41.3±1.235 ±1.75*
30083.8±5.1116.6±6.9*41 ±1.536.3±1.3*

Each value is mean±SEM

P<0.05

Table 2

Effect of glibenclamide on H2S-induced changes on glucose and insulin level

Time (min)Glucose (mg %)
Insullin(μU/ml)
Saline treated groupH2S + glibenclamide-treated groupSaline treated groupH2S + glibenclamide-treated group
081.6±2.679.5±2.738 ±1.940 ±0.9
3083.5±2.984.7±3.641.6 ±0.742.3 ±1.2
6086.3±4.186.6±5.243±1.241.9±1.3
12084.2±3.585.4±4.142.2±1.444.1±1.6
18088.7±3.285.7±440 ±242 ± 1.5
24085.6±483.2±6.340.7±0.842.7±1.2
30087.5±3.983.8±5.140 ±1.542±0.8

Each value is mean±SEM, *P<0.05

Effect of H2S on glucose and insulin level Each value is mean±SEM P<0.05 Effect of glibenclamide on H2S-induced changes on glucose and insulin level Each value is mean±SEM, *P<0.05

Effect of H2S on insulin resistance

After chronic treatment with H2S, oral glucose tolerance test was performed to check the development of insulin resistance. Glucose level was measured after administration of glucose 5 g/kg p.o. There was no significant difference in glucose level compared to normal animals [Figure 1].
Figure 1

Effect of chronic administration of H2S on oral glucose tolerance. Each value is mean±SEM, *P<0.05

Effect of chronic administration of H2S on oral glucose tolerance. Each value is mean±SEM, *P<0.05 After chronic treatment with H2S, oral glucose tolerance test was performed along with administration of insulin 1 U/kg i.m to check the development of insulin sensitivity. Glucose level was measured after administration of glucose 5 g/kg p.o. There was no significant difference in glucose level compared to normal animals [Figure 2]. Also there was no significant difference in insulin and glucose level before and after chronic administration of H2S [Table 3].
Figure 2

Effect of chronic administration of H2S on oral glucose tolerance. Each value is mean±SEM, *P<0.05

Table 3

insulin and glucose level before and after 30 days treatment of H2S

Glucose level (mg %)Insullin(μU/ml)
Before 30 days treatment of H2S82.4±1.8342.12±0.54
After 30 days treatment of H2S82.8±1.1241.7±0.36

Each value is mean±SEM, *P<0.05

Effect of chronic administration of H2S on oral glucose tolerance. Each value is mean±SEM, *P<0.05 insulin and glucose level before and after 30 days treatment of H2S Each value is mean±SEM, *P<0.05

DISCUSSION

The islets of Langerhans contain four main cell types, out of them β cells secrete insulin. The main factor controlling the synthesis and secretion of insulin is the blood glucose concentration. ATP-sensitive K+-channel determines the resting membrane potential in β cells via a membrane transporter called Glut-2 and its subsequent metabolism via glycosidase and glycolysis increases intracellular ATP. This blocks K+ATP causing membrane depolarization and opening of voltage dependant calcium channels, leading to Ca+ signal induces insulin secretion. The insulin secretion is depending upon K+ATP channel opening and closing. H2S is K+ATP channel opener and it has no effect of ATP concentration, may be acting by direct interaction with protein.[13] So, it may have effect on pancreatic K+ATP channel. To study the effect of H2S, NaHS was used as a source to release H2S in vivo. The effect of H2S on insulin and glucose level were studied by giving NaHS 2 mg/kg i.p and the blood samples were collected before and after NaHS administration up to 5 h. The glucose and insulin levels were determined in serum. The glucose level was significantly higher and insulin level was significantly lower in animals treated with the NaHS compared to that in the control group. According to our study, H2S increases glucose level and decreases insulin level and this effect of H2S was inhibited by glibenclamide. That confirms ATP-dependant K channel opening activity of H2S in β cells. According to Jia, H2 S concentration was reported to be higher in Zuker diabetic rats as compared to that in and Zuker lean rats. Expressions of both the enzymes responsible for H2S production, CSE and CBS, were also high in streptozotocin-induced diabetic rats.[6] The overexpressing of these enzymes was also reported in patients having type II diabetes.[6] Probably H2S should be having some role in etiology of insulin resistance. So, direct study was conducted by administering H2S to the animals chronically and observing changes in insulin sensitivity. After 30 days treatment with H2S, neither insulin nor glucose level got altered. Glucose utilization was also not changed. Thus, chronic treatment of H2S for 1 month has no significant effects on insulin sensitivity. H2S level was also high in streptozotocin-induced diabetic rats compared to saline-treated rats. High level of H2S is because of overexpression of H2S forming enzymes.[6] So, H2S is not responsible for development of diabetes, but high H2S level in diabetes is due to overexpression of H2S producing enzyme. This over expression of enzymes is may be due to metabolic disturbance in diabetes. A characteristic of streptozotocin-induced diabetes is strong reduction of the pancreatic insulin stores, decreased basal insulin levels, and lack of plasma insulin response to glucose in vivo.[14] This decrease in insulin level and lack of plasma insulin response to glucose may be due to high H2S level in these diabetic animals. Also in Zuker diabetic fatty rats insulin level is low, it may be due to high level of H2S. During OGTT, the increase in serum insulin level of Zuker diabetic fatty (ZDF) rats was delayed with much lower amplitude as compared with that of ZL rats. Treatment with H2S producing enzyme inhibitor, DL-propargylglycine (PPG), elevates the basal level of serum insulin of ZDF rats. Both the rate of increase and the peak amplitude of serum insulin level of PPG-treated ZDF rats were significantly increased in comparison with that of untreated ZDF rats.[15]

CONCLUSION

From the result of our study, it can be concluded that H2S is pancreation K+ATP channel opener and it inhibit insulin secretion. High H2S level in streptozotocin-induced diabetic rat and ZDF rat is responsible for the low level of insulin and it does not have any role in development of insulin resistance. So, H2S can be a good target to treat diabetes but further detail investigation of role of H2S in insulin resistance is require to study.
  12 in total

1.  Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.

Authors:  M Stumvoll; A Mitrakou; W Pimenta; T Jenssen; H Yki-Järvinen; T Van Haeften; W Renn; J Gerich
Journal:  Diabetes Care       Date:  2000-03       Impact factor: 19.112

2.  A sensitive radioimmunoassay of insulin autoantibody: reduction of non-specific binding of [125I]insulin.

Authors:  Hiroshi Murayama; Nobuo Matsuura; Tomoyuki Kawamura; Taro Maruyama; Nobuyuki Kikuchi; Tetsuro Kobayashi; Fumi Nishibe; Atsuo Nagata
Journal:  J Autoimmun       Date:  2006-01-05       Impact factor: 7.094

3.  Streptozotocin-induced diabetes in the rat is associated with enhanced tissue hydrogen sulfide biosynthesis.

Authors:  Muhammed Yusuf; Benny Tan Kwong Huat; A Hsu; Matthew Whiteman; Madhav Bhatia; Philip K Moore
Journal:  Biochem Biophys Res Commun       Date:  2005-08-12       Impact factor: 3.575

4.  Pharmacokinetics and pharmacodynamics of diclofenac in the presence and absence of glibenclamide in the rat.

Authors:  María R León-Reyes; Gilberto Castañeda-Hernández; Mario I Ortiz
Journal:  J Pharm Pharm Sci       Date:  2008       Impact factor: 2.327

5.  Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?

Authors:  Rui Wang
Journal:  FASEB J       Date:  2002-11       Impact factor: 5.191

6.  The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide.

Authors:  R Hosoki; N Matsuki; H Kimura
Journal:  Biochem Biophys Res Commun       Date:  1997-08-28       Impact factor: 3.575

7.  Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats.

Authors:  Yi Zhun Zhu; Zhong Jing Wang; Peiying Ho; Yoke Yun Loke; Yi Chun Zhu; Shan Hong Huang; Chee Sin Tan; Matt Whiteman; Jia Lu; Philip K Moore
Journal:  J Appl Physiol (1985)       Date:  2006-10-12

8.  H(2)S-induced vasorelaxation and underlying cellular and molecular mechanisms.

Authors:  Weimin Zhao; Rui Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-08       Impact factor: 4.733

9.  Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat.

Authors:  M H Stipanuk; P W Beck
Journal:  Biochem J       Date:  1982-08-15       Impact factor: 3.857

10.  Pancreatic islet overproduction of H2S and suppressed insulin release in Zucker diabetic rats.

Authors:  Lingyun Wu; Wei Yang; Xuming Jia; Guangdong Yang; Dessislava Duridanova; Kun Cao; Rui Wang
Journal:  Lab Invest       Date:  2008-11-10       Impact factor: 5.662

View more
  8 in total

Review 1.  Roles of hydrogen sulfide in the pathogenesis of diabetes mellitus and its complications.

Authors:  Csaba Szabo
Journal:  Antioxid Redox Signal       Date:  2012-01-30       Impact factor: 8.401

2.  Evaluation of plasma H2S levels and H2S synthesis in streptozotocin induced Type-2 diabetes-an experimental study based on Swietenia macrophylla seeds.

Authors:  Moumita Dutta; Utpal Kumar Biswas; Runu Chakraborty; Piyasa Banerjee; Utpal Raychaudhuri; Arun Kumar
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

Review 3.  Regulation of carbohydrate metabolism by nitric oxide and hydrogen sulfide: Implications in diabetes.

Authors:  Sevda Gheibi; Alan P Samsonov; Shahsanam Gheibi; Alexandra B Vazquez; Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2020-01-21       Impact factor: 5.858

4.  Hydrogen sulfide regulates Ca(2+) homeostasis mediated by concomitantly produced nitric oxide via a novel synergistic pathway in exocrine pancreas.

Authors:  Amira Moustafa; Yoshiaki Habara
Journal:  Antioxid Redox Signal       Date:  2013-10-19       Impact factor: 8.401

Review 5.  Hydrogen sulfide signaling in mitochondria and disease.

Authors:  Brennah Murphy; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  FASEB J       Date:  2019-10-24       Impact factor: 5.834

Review 6.  Cysteine and hydrogen sulphide in the regulation of metabolism: insights from genetics and pharmacology.

Authors:  Roderick N Carter; Nicholas M Morton
Journal:  J Pathol       Date:  2015-11-13       Impact factor: 7.996

7.  Fluidics system for resolving concentration-dependent effects of dissolved gases on tissue metabolism.

Authors:  Varun Kamat; Brian M Robbings; Seung-Ryoung Jung; John Kelly; James B Hurley; Kenneth P Bube; Ian R Sweet
Journal:  Elife       Date:  2021-11-04       Impact factor: 8.140

Review 8.  The role of hydrogen sulfide in aging and age-related pathologies.

Authors:  Bernard W Perridon; Henri G D Leuvenink; Jan-Luuk Hillebrands; Harry van Goor; Eelke M Bos
Journal:  Aging (Albany NY)       Date:  2016-09-27       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.